Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001373604-25-000060
Filing Date
2025-04-16
Accepted
2025-04-16 09:16:44
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 7641
2 bmlletter.htm EX-1 2874
  Complete submission text file 0001373604-25-000060.txt   12298
Mailing Address 65 E CEDAR - SUITE 2 ZIONSVILLE IN 46077
Business Address 65 E CEDAR - SUITE 2 ZIONSVILLE IN 46077 317-344-2447
BML Investment Partners, L.P. (Filed by) CIK: 0001373604 (see all company filings)

EIN.: 383708345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D

Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Subject) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-92657 | Film No.: 25841370
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)